Odelniqva (Dapagliflozin)

Dapagliflozin, the active ingredient in Odelniqva, is a SGLT2 inhibitor presented as a strength/form for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. GNH USA supplies Odelniqva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Odelniqva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Odelniqva (dapagliflozin) acts ​          ​      ​      ​        ​      ​        ​ ​ ​  ​  ​ ​ ​ ​ - Type         ?  ?  …  …  … -  …  …  ...  ...  ...  …  -  … …  ...  ...